Facial palsy

40,358 views 30 slides Jun 11, 2018
Slide 1
Slide 1 of 30
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30

About This Presentation

the content of this topic taken many artical nd std. books thank you...


Slide Content

FACIAL PALSY Dr. Vibhash Kumar Vaidya

Contents Introduction Anatomy Epidemiology Cause Clinical Features Differential Diagnosis Ramse Hunt syndrome Evaluation & Diagnosis

Treatment Prognosis Complications Physiotherapy management

Introduction Facial palsy accounts for 75% of cases of acute facial nerve (7 th cranial nerve) paralysis Imaging is not needed in majority of patients unless they have atypical features W/atypical features, MR & CT may demonstrate potentially treatable lesions affecting facial nerves Facial nerves can be affected anywhere along their course

Sir Charles Bell, Scottish Surgeon First described in early 1800s based on trauma to facial nerves Definition of Bell’s Palsy: Acute peripheral CN VII (facial nerve) palsy of unknown cause

Anatomy of Facial nerve The facial nerve contains approximately 10,000 fibers 7000 myelinated fibers innervate the muscles of facial expression, stapedius muscle, postauricular muscles, posterior belly of digastric muscle, and platysma 3000 fibers form the nervus intermedius ( Nerve of Wrisberg ) sensory fibers ( taste ) from the anterior 2/3 of the tongue taste fibers from soft palate via palatine and greater petrosal nerve parasympathetic secretomotor fibers to the parotid, submandibular, sublingual, and lacrimal gland

Anatomy of Facial nerve 1) Intracranial part Supranuclear segment Nuclear segment Infranuclear segment Cerebellopontine angle Internal acoustic canal Labyrinthine segment Tympanic segment Mastoid segment 2) Extracranial part

Supranuclear segment Cerebral cortex  Corticobulbar tract  Facial nucleus (pons) Upper face  crossed & uncrossed Lower face  crossed only

Nuclear segment Facial motor nucleus lower 1/3 of Pons abducent nucleus Out from brain stem at pons recess between olive and inferior cerebellar peduncle

Infranuclear segment Cerebellopontine angle Internal acoustic canal Labyrinthine segment Tympanic segment Mastoid segment

Cerebellopontine angle The facial nerve and nervus intermedius exit the brain stem at the pontomedullary junction and travel with CN VIII to enter the internal acoustic meatus

Internal acoustic canal Motor facial nerve (medial) N ervus intermedius (between) Acoustic nerve (lateral)

Labyrinthine segment Fallopian canal Shortest & Narrowest part Temporal bone Facial nerve enter fallopian canal until middle ear First genu Geniculate ganglion Branches Greater superficial petrosal nerve  lacrimal gland Lessor superficial petrosal nerve  parotid gland

Tympanic segment First genu  above oval window  stapes Second genu beyond middle ear Out of cranium through stylomastoid foramen

Mastoid segment Stylomastoid foramen Branches Motor nerve to stapedius muscle Chorda tympani nerve between malleus and incus secretomotor : Submandibular & Sublingual gland taste fiber : anterior 2/3 of tongue

Extracranial segment Posterior auricular nerve : auricularis , occipitalis and sensation at auricular, post auricular area Branch to posterior belly of digastric muscle and stylohyoid muscle T emporal branch : muscle above zygoma Z ygomatic branch : orbicularis occli B uccal branch : buccinator and upper lip M arginal mandibular branch : orbicularis oris and lower lip C ervical branch : platysma

Epidemiology ½ of all facial palsy’s qualify as “Bell’s Palsy” Annual Incidence 10-40/100,000 Lifetime incidence 1:60 Risk is 3xs greater in pregnancy, especially 3 rd trimester Increased risk with diabetes

Cause Widely accepted cause is HSV-1, however not proven HSV mediates inflammatory/immune response which leads to myelin sheath degeneration, & edema which causes compression and further damage of CN VII

Clinical Features Sudden onset symptoms, usually hours w/ maximal weakness w/in 48 hrs Unilateral Eyebrow sagging Inability to close eye Loss of nasolabial fold Decreased tearing Hyperacusis Loss of taste to anterior 2/3 tongue Mouth droop

Differential Diagnosis Infection External otitis Otitis media Mastoiditis Chickenpox Herpes zoster (Ramsey Hunt syndrome) Encephalitis Poliomyelitis (type I) Mumps Mononucleosis Leprosy Influenza Coxsackievirus Malaria Syphilis Tuberculosis Botulism Lyme disease Tumor, central or local Metabolic DM Hyperthyroidism Vitamin A deficiency Toxic Iatrogenic Idiopathic Bell's Melkersson -Rosenthal syndrome (recurrent alternating facial palsy, furrowed tongue) Amyloidosis Landry- Guillain - Barre syndrome Multiple sclerosis Myasthenia gravis Sarcoidosis Birth Trauma

Herpes Zoster Oticus ( Ramsay Hunt Syndrome ) 3 rd most common of peripheral facial paralysis (10%) Aged > 60 yrs. or low immune (low CMIR) Virus travels to the dorsal root extramedullary cranial nerve ganglion Infected of HZV at auricular, external canal or face Prodromal symptoms very similar to those seen in Bell's palsy but usually more severe

Herpes Zoster Oticus ( Ramsay Hunt Syndrome ) Symptoms include severe otalgia, facial paralysis, facial numbness, and a vesicular eruption on the concha, external auditory canal, and palate Facial paralysis + hearing loss + vertigo  “ canal paralysis ” Pathophysiology & treatment liked in Bell ’s palsy

Evaluation & Diagnosis Bell’s Palsy is a clinical diagnosis based on typical presentation absence of other explanation or other underlying disease absence of cutaneous lesions otherwise normal neuro exam Possible Labs to check: ESR, RPR, Lyme titer, glucose, PCR if vesicular lesions Proceed with imaging (MRI) if Atypical Presentation Slowly progressive over 2-3 weeks If no improvement in symptoms in 6 wks Electrophysiology (CMAP) performed if complete facial paralysis remains after 1 week of treatment

Treatment Manual closing of eye such as with tape while sleeping, lubricating eye drops Steroids 60-80 mg daily x 5 days then tapered over next 5 days or 1 mg/kg daily x 7 days +/-Acyclovir 400 mg 5xs daily x 10 days vs Valacyclovir 1 g BID x 7 days Surgical Decompression – no good evidence to support

Prognosis 80% recover within weeks to months If motor nerve conduction studies show evidence of denervation after 10 days indicates prolonged recovery of ~ 3 months & possible incomplete recovery

Complications Complications of facial nerve decompression dural tears conductive or sensorineural hearing loss vestibular function loss persistent CSF leaks meningitis injury to the anterior inferior cerebellar artery (AICA) or its branches

PHYSIOTHERAPY MANAGEMENT GOALS 1- to educate patient about the condition. 2- to relief pain. 3- to establish the bases for re-education of muscle and nerve conduction. 4- to re-educate the sensation if involved. 5- to improve muscle contraction. 6- to improve facial symmetry. 7- to prevent complications.
Tags